Dartmouth researchers find that certain genetic variants may help identify patients at increased risk of bladder cancer recurrence
A new study published in BJU International, “Genetic polymorphisms modify bladder cancer recurrence and survival in a U.S. population-based prognostic study,” suggests that certain inherited DNA sequences may affect a bladder cancer patient’s prognosis. These findings may help physicians identify sub-groups of high risk bladder cancer patients who should receive more frequent screenings and aggressive treatment and monitoring.
Click here to read the full press release.
Among the research institutions NCI funds across the United States, it currently designates 68 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.